Through April 23, the broad-based S&P 500 was up 17% year to date, representing one of its strongest starts to a year in decades. Comparatively, though, the Horizons Marijuana Life Sciences ETF, the first cannabis exchange-traded fund, had gained 45%, making the broader market’s big gains seem tiny. One area that could continue to push forward the Horizon ETF’s gains, is consumer facing CBD products. Products like CBD gums are something which golfers Tiger Woods and Phil Mickelson are rumored to be chewing. The non-psychoactive health benefits of CBD are appealing for golfers.
This is why we are highlighting Real Brands, Inc. (RLBD). The Hemp-Derived consumer product company just announced that PGA professional Scott Piercy is coming aboard as Brand Ambassador. Last month, he made a further commitment by making a long-term investment into Real Brands. RLBD has strong management with a solid background in branding and the beverage industry and plans to expand their holdings focusing on at least three CBD Categories: smokables, edibles and topical balms and lotions. The company recently updated their logo and brand identity. It is also developing an E-Commerce website and plans to launch it during the early part of the second quarter on their newly acquired domain name, to support online sales of a variety of smokable, edible, and topical CBD derived from hemp-based products for each of their brands. Start your research today. Today we are highlighting: Real Brands, Inc. (RLBD), Valens GrowWorks Corp. (VGWCF), The Brink’s Company (BCO), Aleafia Health, Inc. (ALEAF), and MedMen Enterprises, Inc. (MMNFF).
Real Brands, Inc. (RLBD) (Market Cap: $14.612M; Share Price: $0.097) is launching a CBD beverage. The company is very close to its next production run, meaning there could be major news on the way. The audit on the horizon means this could also be another major event for investors to pay attention to. Real Brands is first and foremost a marketing and branding company, which has been slowly building its portfolio of trademarked brand names that could each represent on their own major partnerships and joint ventures going forward. It is focused on the hemp-derived CBD industry and is developing consumer products in the following categories- smokables, edibles and topicals.
Jerry Pearring, the CEO of Real Brands commented, “As the demand for CBD infused products continues to grow, we intend to create marketing strategies in at least three CBD Categories: smokables, edibles and topical balms and lotions.”
OTHER CANNABIS COS TO RESEARCH INCLUDE:
Valens GrowWorks Corp. (VGWCF) (Market Cap: $374.894M; Share Price: $3.45) has rallied after GMP Securities raised its stock price target after the company’s latest quarterly earnings. GMP analyst, Martin Landry, boosted his price target to $10 from $8 and reiterated his buy rating. Valens’ first-quarter earnings were in line and are mostly immaterial to its earnings power as it remains in the early stages of its growth cycle, he wrote.
But the company’s comments on demand for its extraction services support Landry’s fiscal 2020 forecasts, he wrote in a note to clients, and the company is an ideal partner for potential international consumer packaging companies seeking to source a cannabis-derived product in Canada. Valens is aiming to be the biggest third-party vape pen manufacturer and distributor in Canada, and is developing formulations for drinks and edibles, which will become fully legal in Canada in October.
The experience that security company, The Brink’s Company (BCO) (Market Cap: $3.989B; Share Price: $79.99) is building in Canada could be a boon if the U.S. fully legalizes cannabis at the federal level. Brink’s is currently offering cash and logistics service to Canopy Growth. BCO is not currently serving the U.S. sector, but Chief Executive Doug Pertz told analysts on the company’s earnings call this week that the company supports legislation that would allow banks to work with companies in states that have legalized, as a matter of public safety and policy.
Aleafia Health, Inc. (ALEAF) (Market Cap: $317.782M; Share Price: $1.16852) provided a corporate update and report on its financial results for the year-ended December 31, 2018. “2018 saw Aleafia Health build the foundation for a breakthrough 2019 and beyond. We believe that our strategically placed assets, strong management team and distribution channels will allow us to scale our global mission of growing, processing and selling high-margin, value-added cannabis health and wellness products,” said Aleafia Health CEO Geoffrey Benic. “It is a testament to the executional capabilities and commitment of our team that Aleafia Health has grown from a pre-revenue business to one of the largest licensed producers in under one year.”
MedMen Enterprises, Inc. (MMNFF) (Market Cap: $259.693M; Share Price: $2.779) announced the opening of its Sorrento Valley store in San Diego, California. This is the second MedMen location in the San Diego area and the Company’s 11th operational MedMen location in California.
– Priyanka Goel, CFA
This article was written by Regal Consulting, LLC (“Regal Consulting”). Regal Consulting has agreed to a three-month term consulting agreement with RLBD dated 8/31/18. The agreement calls for $100,000 note issued to Regal Consulting, and 2,500,000 restricted 144 shares of RLBD for three months of service. Regal has elected to convert $73,000 of principal of the $100,000 note into 2,761,872 Restricted 144 shares of RLBD. Regal Consulting has agreed to a twelve- month term consulting agreement with RLBD dated 1/4/2019. The agreement calls for $10,000 in cash and 500,000 shares per month. All payments were made directly by Real Brands, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. RLBD was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.
For more information, visit: http://www.regalconsultingllc.com/full legal disclaimer/
Full Legal Disclaimer Click Here.